Filtered Listing Testing
The first-ever Alzheimer’s blood test was brought to market with support from BrightFocus. In this Q&A, one of its chief developers describes how the test is being used in practice.
First-ever Alzheimer’s blood test is now available in the United States and Europe. Here’s a history of BrightFocus’ support, from discovery stage to the clinic.
Learn about the new grants available this year for Macular Degeneration Research.
Learn about how a test allows clinicians to accurately detect signs of Alzheimer's Disease from a single blood draw.
Johns Hopkins University’s Sheila West, Ph.D., Pharm.D., a world-renowned expert on environmental factors and disparities causing blindness, was this month awarded the 2020 Helen Keller Prize for Vision Research. The Prize, presented by BrightFocus Foundation and the Helen Keller Foundation for Research and Education, honors scientific discovery and excellence and is chosen by an independent awards committee. The award was delayed by one year because of the pandemic.
May 3, 2021—BrightFocus Foundation, a leading private funder of scientific research on diseases of mind and sight, today announced its 2021 named awards for macular degeneration and glaucoma research at the annual meeting of the Association for Research in Vision and Ophthalmology (ARVO).
BrightFocus Foundation announces $25.3 million in new grants.
Recently, when their groundbreaking genetics discovery was featured on the cover of Nature, the research team thanked BrightFocus for critical early funding that supported their accomplishments.
